Literature DB >> 23846426

The role of invariant natural killer T cells in microbial immunity.

Yuki Kinjo1, Naoki Kitano, Mitchell Kronenberg.   

Abstract

Invariant natural killer T cells (iNKT cells) are unique lymphocytes with characteristic features, such as expression of an invariant T-cell antigen receptor (TCR) α-chain, recognition of glycolipid antigens presented by CD1d molecules, and ability to rapidly produce large amounts of cytokines, including interferon-γ (IFN-γ) and interleukin 4 (IL-4) upon TCR stimulation. Many studies have demonstrated that iNKT cells participate in immune response against diverse microbes, including bacteria, fungi, protozoan parasites, and viruses. Generally, these cells play protective roles in host defense against infections. However, in some contexts they play pathogenic roles, by inducing or augmenting inflammation. Recent reports show that iNKT cells recognize glycolipid antigens from pathogenic bacteria including Streptococcus pneumoniae, and they contribute to host defense against infection. iNKT cell responses to these microbial glycolipid antigens are highly conserved between rodents and humans, suggesting that iNKT cells are evolutionally conserved because their invariant TCR is useful in detecting certain pathogens. Furthermore, glycolipid-mediated iNKT cell activation during immunization has adjuvant activity, enhancing humoral and cell-mediated responses. Therefore, iNKT cell activation is an attractive target for developing new vaccines for infectious diseases.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23846426      PMCID: PMC3822041          DOI: 10.1007/s10156-013-0638-1

Source DB:  PubMed          Journal:  J Infect Chemother        ISSN: 1341-321X            Impact factor:   2.211


  88 in total

1.  Detection of sphingomonads and in situ identification in activated sludge using 16S rRNA-targeted oligonucleotide probes.

Authors:  A Neef; R Witzenberger; P Kämpfer
Journal:  J Ind Microbiol Biotechnol       Date:  1999-10       Impact factor: 3.346

Review 2.  NKT cells: what's in a name?

Authors:  Dale I Godfrey; H Robson MacDonald; Mitchell Kronenberg; Mark J Smyth; Luc Van Kaer
Journal:  Nat Rev Immunol       Date:  2004-03       Impact factor: 53.106

3.  Distinct NKT cell subsets are induced by different Chlamydia species leading to differential adaptive immunity and host resistance to the infections.

Authors:  Antony George Joyee; Hongyu Qiu; Shuhe Wang; Yijun Fan; Laura Bilenki; Xi Yang
Journal:  J Immunol       Date:  2007-01-15       Impact factor: 5.422

4.  Regulation of NKT cell development by SAP, the protein defective in XLP.

Authors:  Kim E Nichols; Jamie Hom; Shun-You Gong; Arupa Ganguly; Cindy S Ma; Jennifer L Cannons; Stuart G Tangye; Pamela L Schwartzberg; Gary A Koretzky; Paul L Stein
Journal:  Nat Med       Date:  2005-02-13       Impact factor: 53.440

5.  Cutting edge: the mechanism of invariant NKT cell responses to viral danger signals.

Authors:  Aaron J Tyznik; Emmanuel Tupin; Niranjana A Nagarajan; Min J Her; Chris A Benedict; Mitchell Kronenberg
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

6.  Innate recognition of cell wall β-glucans drives invariant natural killer T cell responses against fungi.

Authors:  Nadia R Cohen; Raju V V Tatituri; Amariliz Rivera; Gerald F M Watts; Edy Y Kim; Asako Chiba; Beth B Fuchs; Eleftherios Mylonakis; Gurdyal S Besra; Stuart M Levitz; Manfred Brigl; Michael B Brenner
Journal:  Cell Host Microbe       Date:  2011-11-17       Impact factor: 21.023

7.  Influenza infection in suckling mice expands an NKT cell subset that protects against airway hyperreactivity.

Authors:  Ya-Jen Chang; Hye Young Kim; Lee A Albacker; Hyun Hee Lee; Nicole Baumgarth; Shizuo Akira; Paul B Savage; Shin Endo; Takashi Yamamura; Janneke Maaskant; Naoki Kitano; Abel Singh; Apoorva Bhatt; Gurdyal S Besra; Peter van den Elzen; Ben Appelmelk; Richard W Franck; Guangwu Chen; Rosemarie H DeKruyff; Michio Shimamura; Petr Illarionov; Dale T Umetsu
Journal:  J Clin Invest       Date:  2010-12-13       Impact factor: 14.808

8.  Mycobacterial phosphatidylinositol mannoside is a natural antigen for CD1d-restricted T cells.

Authors:  Karsten Fischer; Emmanuel Scotet; Marcus Niemeyer; Heidrun Koebernick; Jens Zerrahn; Sophie Maillet; Robert Hurwitz; Mischo Kursar; Marc Bonneville; Stefan H E Kaufmann; Ulrich E Schaible
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-08       Impact factor: 11.205

Review 9.  The specialized iNKT cell system recognizes glycolipid antigens and bridges the innate and acquired immune systems with potential applications for cancer therapy.

Authors:  Masaru Taniguchi; Takuya Tashiro; Nyambayar Dashtsoodol; Naomi Hongo; Hiroshi Watarai
Journal:  Int Immunol       Date:  2009-10-25       Impact factor: 4.823

10.  Invariant natural killer T cells recognize glycolipids from pathogenic Gram-positive bacteria.

Authors:  Yuki Kinjo; Petr Illarionov; José Luis Vela; Bo Pei; Enrico Girardi; Xiangming Li; Yali Li; Masakazu Imamura; Yukihiro Kaneko; Akiko Okawara; Yoshitsugu Miyazaki; Anaximandro Gómez-Velasco; Paul Rogers; Samira Dahesh; Satoshi Uchiyama; Archana Khurana; Kazuyoshi Kawahara; Hasan Yesilkaya; Peter W Andrew; Chi-Huey Wong; Kazuyoshi Kawakami; Victor Nizet; Gurdyal S Besra; Moriya Tsuji; Dirk M Zajonc; Mitchell Kronenberg
Journal:  Nat Immunol       Date:  2011-09-04       Impact factor: 25.606

View more
  31 in total

1.  Phospholipid signals of microbial infection for the human immune system.

Authors:  Mitchell Kronenberg; Meng Zhao
Journal:  Proc Natl Acad Sci U S A       Date:  2015-12-30       Impact factor: 11.205

2.  Targeted disruption of CD1d prevents NKT cell development in pigs.

Authors:  Guan Yang; Bianca L Artiaga; Timothy J Hackmann; Melissa S Samuel; Eric M Walters; Shahram Salek-Ardakani; John P Driver
Journal:  Mamm Genome       Date:  2015-05-01       Impact factor: 2.957

3.  Recognition of lysophosphatidylcholine by type II NKT cells and protection from an inflammatory liver disease.

Authors:  Igor Maricic; Enrico Girardi; Dirk M Zajonc; Vipin Kumar
Journal:  J Immunol       Date:  2014-09-26       Impact factor: 5.422

Review 4.  Invariant natural killer T cells and their ligands: focus on multiple sclerosis.

Authors:  Joan O'Keeffe; Maria Podbielska; Edward L Hogan
Journal:  Immunology       Date:  2015-06-25       Impact factor: 7.397

Review 5.  Type II NKT cells: a distinct CD1d-restricted immune regulatory NKT cell subset.

Authors:  Suryasarathi Dasgupta; Vipin Kumar
Journal:  Immunogenetics       Date:  2016-07-12       Impact factor: 2.846

Review 6.  Different subsets of natural killer T cells may vary in their roles in health and disease.

Authors:  Vipin Kumar; Terry L Delovitch
Journal:  Immunology       Date:  2014-07       Impact factor: 7.397

7.  Transcription factor Bcl11b sustains iNKT1 and iNKT2 cell programs, restricts iNKT17 cell program, and governs iNKT cell survival.

Authors:  Mohammad Nizam Uddin; Dil Afroz Sultana; Kyle J Lorentsen; Jonathan J Cho; Mariana E Kirst; Mark L Brantly; Danielle Califano; Derek B Sant'Angelo; Dorina Avram
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-21       Impact factor: 11.205

Review 8.  Engaging Natural Killer T Cells as 'Universal Helpers' for Vaccination.

Authors:  Mary Speir; Ian F Hermans; Robert Weinkove
Journal:  Drugs       Date:  2017-01       Impact factor: 9.546

Review 9.  Invariant natural killer T cells: front line fighters in the war against pathogenic microbes.

Authors:  Catherine M Crosby; Mitchell Kronenberg
Journal:  Immunogenetics       Date:  2016-07-01       Impact factor: 2.846

10.  Syndecan-1 identifies and controls the frequency of IL-17-producing naïve natural killer T (NKT17) cells in mice.

Authors:  Hong Dai; Ayesha Rahman; Ankit Saxena; Anil K Jaiswal; Abdiaziz Mohamood; Lourdes Ramirez; Sanjeev Noel; Hamid Rabb; Chunfa Jie; Abdel Rahim A Hamad
Journal:  Eur J Immunol       Date:  2015-09-10       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.